ATE275401T1 - Herstellung von inogatran-agglomeraten und die verbindung inogatran-anhydrid - Google Patents

Herstellung von inogatran-agglomeraten und die verbindung inogatran-anhydrid

Info

Publication number
ATE275401T1
ATE275401T1 AT00941066T AT00941066T ATE275401T1 AT E275401 T1 ATE275401 T1 AT E275401T1 AT 00941066 T AT00941066 T AT 00941066T AT 00941066 T AT00941066 T AT 00941066T AT E275401 T1 ATE275401 T1 AT E275401T1
Authority
AT
Austria
Prior art keywords
inogatran
compound
agglomerates
anhydride
preparation
Prior art date
Application number
AT00941066T
Other languages
English (en)
Inventor
Karol Horvath
Bo Lindqvist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE275401T1 publication Critical patent/ATE275401T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT00941066T 1999-06-10 2000-06-06 Herstellung von inogatran-agglomeraten und die verbindung inogatran-anhydrid ATE275401T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9902202A SE9902202D0 (sv) 1999-06-10 1999-06-10 Production of aggregates
PCT/SE2000/001165 WO2000076504A1 (en) 1999-06-10 2000-06-06 Production of agglomerates of inogatran and the compound inogatran anhydrate

Publications (1)

Publication Number Publication Date
ATE275401T1 true ATE275401T1 (de) 2004-09-15

Family

ID=20416034

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00941066T ATE275401T1 (de) 1999-06-10 2000-06-06 Herstellung von inogatran-agglomeraten und die verbindung inogatran-anhydrid

Country Status (8)

Country Link
US (2) US6531490B1 (de)
EP (1) EP1191932B1 (de)
JP (1) JP2003501465A (de)
AT (1) ATE275401T1 (de)
AU (1) AU5582700A (de)
DE (1) DE60013599T2 (de)
SE (1) SE9902202D0 (de)
WO (1) WO2000076504A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
US9668975B2 (en) 2014-10-14 2017-06-06 PharmaDax Inc. Method of preparing drug agglomerate

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58143832A (ja) * 1982-02-22 1983-08-26 Yoshiaki Kawashima 結晶性化学物質の球状化再結晶法
JPH01279869A (ja) * 1988-01-28 1989-11-10 Dainippon Pharmaceut Co Ltd 類球形結晶およびその析出方法
JPH0477422A (ja) * 1990-07-18 1992-03-11 Eisai Co Ltd 塩酸クロルプレナリンの球形造粒物及びその製造方法
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9601556D0 (sv) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
DK0907639T3 (da) * 1996-06-24 2003-06-23 Novartis Ag Polymorfe forbindelser
US6506564B1 (en) * 1996-07-29 2003-01-14 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US7098320B1 (en) * 1996-07-29 2006-08-29 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
SE9603724D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New pharmaceutical parenteral formulation of a thrombin inhibitor
AU1917999A (en) * 1998-03-31 1999-10-18 Warner-Lambert Company Quinoxalinones as serine protease inhibitors such as factor xa and thrombin
MXPA01002908A (es) * 1998-09-21 2002-04-08 E Purdum Howard Metodos y aparatos para procesar materiales sensibles a la temperatura.
DE19856149C1 (de) * 1998-12-04 2000-06-15 Basf Ag Verfahren zur Herstellung von Agglomeraten mit Kern-Schale-Struktur
GB9903472D0 (en) * 1999-02-17 1999-04-07 Zeneca Ltd Chemical process
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2797875B1 (fr) * 1999-08-26 2001-10-19 Hoechst Marion Roussel Inc Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
US6790228B2 (en) * 1999-12-23 2004-09-14 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same

Also Published As

Publication number Publication date
DE60013599T2 (de) 2005-09-15
AU5582700A (en) 2001-01-02
DE60013599D1 (de) 2004-10-14
US20030134875A1 (en) 2003-07-17
EP1191932A1 (de) 2002-04-03
EP1191932B1 (de) 2004-09-08
US6531490B1 (en) 2003-03-11
WO2000076504A1 (en) 2000-12-21
SE9902202D0 (sv) 1999-06-10
JP2003501465A (ja) 2003-01-14

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
ZA9710796B (en) Oxyiminopregnanecarbolactones.
AU2002352832A1 (en) 3-alkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and 3,3'-dialkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and processes for making them
AU2002358667A1 (en) Scented polymer capsules and the production thereof
DZ3079A1 (fr) Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
AU2002365394A1 (en) Process for preparing 3,3',5,5',6,6'-hexaalkyl-2,2'-biphenols, 3,3',4,4',5,5'-hexaalkyl-2,2'-biphenols and 3,3',4,4',5,5',6,6'-octaalkyl-2,2'-biphenols
MXPA03009527A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE INDENOS 1,3-SUSTITUIDOS Y COMPUESTOS AZAPOLICICLICOS CONDENSADOS CON ARILO.
PL336640A1 (en) Substituted 3,3-diamino-2- propenonitriles, their production and application
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
WO2001049654A3 (de) Substituierte aminomethyl-phenyl-cyclohexanderivate
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
MXPA04004937A (es) Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
MXPA03008837A (es) Una composicion farmaceutica estable de pravastatina.
CA2369825A1 (en) Microstructured components
ATE275401T1 (de) Herstellung von inogatran-agglomeraten und die verbindung inogatran-anhydrid
CA2399709A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
MXPA03002926A (es) Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina.
AU5419699A (en) Methoximinophenylacetic acid amides
CZ20022240A3 (cs) Mannichovy báze substituovaného 1-a 2-naftolu
CA2292017A1 (en) Substituted cycloheptenes, their preparation and use
YU62800A (sh) Postupak za proizvodnju r-(+)-6- karboksamido-3n-metilamino- 1,2,3,4-tetrahidrokarbazola
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
ZA200001642B (en) Novel substituted 1,2,4-trioxanes as antimalarial agents and a process of producing the substituted 1,2,4-trioxanes.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties